Details for Patent: 9,867,810

Which drugs does patent 9,867,810 protect, and when does it expire?

Patent 9,867,810 protects QLOSI and is included in one NDA.

This patent has twenty-three patent family members in fourteen countries.

Summary for Patent: 9,867,810

Title:	Ophthalmic pharmaceutical compositions and uses relating thereto
Abstract:	The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
Inventor(s):	Claes Feinbaum, Franc SALAMUN, Sudhir PATEL
Assignee:	Orasis Pharmaceuticals Ltd
Application Number:	US15/680,967
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 9,867,810

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes			Y			TREATMENT OF PRESBYOPIA

International Family Members for US Patent 9,867,810

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017311636
Australia	2023226732
Brazil	112019002967
Canada	3031370